KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Revenue (2016 - 2024)

Novartis Ag's Revenue history spans 13 years, with the latest figure at $12.5 billion for Q2 2024.

  • On a quarterly basis, Revenue fell 52.92% to $12.5 billion in Q2 2024 year-over-year; TTM through Jun 2024 was $35.3 billion, a 32.93% increase, with the full-year FY2025 number at $54.5 billion, up 8.38% from a year prior.
  • Revenue hit $12.5 billion in Q2 2024 for Novartis Ag, down from $22.2 billion in the prior quarter.
  • Over the last five years, Revenue for NVS hit a ceiling of $42.0 billion in Q4 2021 and a floor of $226.0 million in Q3 2021.
  • Historically, Revenue has averaged $11.2 billion across 5 years, with a median of $302.5 million in 2021.
  • Biggest five-year swings in Revenue: skyrocketed 17268.6% in 2021 and later crashed 99.4% in 2022.
  • Tracing NVS's Revenue over 5 years: stood at $242.0 million in 2020, then skyrocketed by 17268.6% to $42.0 billion in 2021, then crashed by 99.4% to $254.0 million in 2022, then soared by 8653.94% to $22.2 billion in 2023, then crashed by 43.73% to $12.5 billion in 2024.
  • Business Quant data shows Revenue for NVS at $12.5 billion in Q2 2024, $22.2 billion in Q4 2023, and $26.6 billion in Q2 2023.